CMPS
COMPASS Pathways plcNASDAQHealthcare$5.79+3.02%ClosedMarket Cap: $556.3M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
-10.26
P/S
0.00
EV/EBITDA
-1.87
DCF Value
$1.38
FCF Yield
-28.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-335.9%
ROA
-136.8%
ROIC
996.5%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | -Infinity% | $-46.0M | $-93.9M | $-1.00 | — |
| FY 2025 | $0.00 | -Infinity% | $-179.0M | $-287.9M | $-3.08 | — |
| Q3 2025 | $0.00 | NaN% | $-40.5M | $-137.7M | $-1.44 | — |
| Q2 2025 | $0.00 | NaN% | $-42.9M | $-38.4M | $-0.41 | — |
| Q1 2025 | $0.00 | NaN% | $-49.6M | $-17.9M | $-0.24 | — |
| Q4 2024 | $0.00 | NaN% | $-48.4M | $-43.3M | $-0.63 | — |
| FY 2024 | $0.00 | NaN% | $-178.2M | $-155.1M | $-2.30 | — |
| Q3 2024 | $0.00 | NaN% | $-47.9M | $-38.5M | $-0.56 | — |
| Q2 2024 | $0.00 | NaN% | $-43.3M | $-38.1M | $-0.56 | — |
| Q1 2024 | $0.00 | NaN% | $-38.6M | $-35.2M | $-0.55 | — |
| Q4 2023 | $0.00 | NaN% | $-38.4M | $-32.5M | $-0.53 | — |
| FY 2023 | $0.00 | NaN% | $-136.9M | $-118.5M | $-2.32 | — |